Form 4: Exact Sciences EVP Brian Baranick Reports Stock Sale

Brian Baranick, EVP and GM of Precision Oncology at Exact Sciences, reported the sale of 929 shares of common stock at $70 per share on September 18, 2024, according to a Form 4 filing.

Summary

• On September 18, 2024, Brian Baranick, EVP, GM, Precision Oncology at Exact Sciences Corp, sold 929 shares of common stock at a price of $70 per share.
• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan established on May 24, 2023.
• Following the reported transaction, Baranick directly owns 13,687 shares of common stock.
• Baranick also indirectly owns 454 shares of common stock held in a 401(k) plan.
• In addition to the directly held shares, Baranick holds 65,007 vested and unvested options and restricted stock units, each representing a contingent right to receive one share of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a stock sale under a pre-existing trading plan, with no explicit indication of positive or negative sentiment towards the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The stock sale by an executive could be perceived negatively by some shareholders, although the existence of a pre-arranged trading plan mitigates this concern.

Key Dates